Debt is 59% of the $220M headline [1], and the $130M from VerisFi Capital and Atempo Growth sits at 0.79 times an annualised run rate the company puts above $165M [3][16][2]. Neither write-up discloses pricing, covenants, or whether the facilities are drawn, and that gap matters more than the composition of the equity syndicate does, because a facility advanced against receivables and a covenanted term loan behave very differently in a quarter that misses.
The case for calling booking the binding constraint is Charlie Bullock's own: labs got a national front door decades ago through Quest Diagnostics and Labcorp, and imaging never did [9], while roughly 85% of US scans are still arranged by fax or telephone [5] in a market the company sizes above $100B [4]. What the product sells against that is the removal of per-facility plumbing, one API covering search, scheduling and results delivery [8], integrating into independent centres' own scheduling systems and electronic records [22]. Against a $100B denominator, a $165M run rate is 0.165% [4], which is the same thing Bullock means when he calls the company a small participant in the wider US market [18]. Or rather, the more interesting version of that number: more than 900,000 patients since 2021 [12][19] divided into the current run rate puts revenue per patient above $183 [5], a floor rather than an average, since the patient count is cumulative and global while the revenue is annualised and mostly American [15].
The failure mode here is specific. If the queue is scanners and radiologists rather than fax machines, a better router moves the wait instead of removing it, and the tell arrives as volume growing while the take thins, because Scan.com is bidding for slots at centres it does not own [22]. The sources name the frictions (offline booking, waits of weeks, idle scanner capacity, price dispersion between nearby centres for the same MRI [5][6][7]) without measuring how much of any given patient's wait each one accounts for, and all of it reaches a reader through the company itself: thesaasnews cites Scan.com's press release and dates the round 31 August 2026 [23].
Revenue has doubled once, from $85M last year to the run rate above $165M, a factor of 1.94 [17][16][3]. Doing it again means routing roughly another $165M of scans through the same network [6], and with $130M borrowed against it, that runs on a lender's calendar rather than an investor's.
